Clinical Trial Update: Dose Escalation by Boosting Radiation Dose Within the Primary Tumor Using 18FDG-PET/CT for Unresectable Thoracic Esophageal Cancer [Phase 1, Phase 2]

View source ↗

Summary

This clinical trial is exploring dose-escalation radiation therapy guided by 18F-FDG PET/CT for unresectable thoracic esophageal cancer in Phase 1/2.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Esophageal Cancer

Snippet

Sponsor: Fudan University | Conditions: Esophageal Cancer | Phase 1, Phase 2 | Status: UNKNOWN